Hemodynamic monitoring in pulmonary arterial hypertension

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Pulmonary arterial hypertension (PAH) is a progressive disease that results in elevation of the pulmonary artery pressure and ultimately development of right ventricular failure. Baseline and periodic invasive hemodynamics via right heart catheterization are generally obtained in order to characterize and follow the extent of hemodynamic derangement, response to therapy, and as an end point in clinical trials of novel therapy. Therapy for PAH is steadily evolving, with considerable uncertainty regarding optimal dosing and comparative efficacy of the available therapeutic agents. Ambulatory hemodynamic monitoring techniques are under development that facilitate availability of hemodynamic parameters ad libitum. Such techniques provide novel insights into cardiovascular pathophysiology during activity and may prove to be useful in allowing early detection of hemodynamic changes between clinic visits. Hemodynamics obtained from implantable monitors have been used during PAH medical therapy in pilot studies and could be used as an end point in clinical trials of PAH therapy. Future efforts should focus on proof of clinical utility of implantable monitoring and refinement of cardiac output estimation by pressure waveform analysis.

Original languageEnglish (US)
Pages (from-to)173-178
Number of pages6
JournalExpert Review of Respiratory Medicine
Volume5
Issue number2
DOIs
StatePublished - Apr 2011

Fingerprint

Pulmonary Hypertension
Hemodynamics
Therapeutics
Clinical Trials
Pressure
Ambulatory Monitoring
Cardiac Catheterization
Ambulatory Care
Cardiac Output
Pulmonary Artery
Uncertainty

Keywords

  • hemodynamics
  • implantable hemodynamic monitors
  • pulmonary arterial hypertension
  • right heart failure

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Immunology and Allergy
  • Public Health, Environmental and Occupational Health

Cite this

Hemodynamic monitoring in pulmonary arterial hypertension. / Frantz, Robert.

In: Expert Review of Respiratory Medicine, Vol. 5, No. 2, 04.2011, p. 173-178.

Research output: Contribution to journalArticle

@article{4e0e090c18c04d16af0c8f504b391179,
title = "Hemodynamic monitoring in pulmonary arterial hypertension",
abstract = "Pulmonary arterial hypertension (PAH) is a progressive disease that results in elevation of the pulmonary artery pressure and ultimately development of right ventricular failure. Baseline and periodic invasive hemodynamics via right heart catheterization are generally obtained in order to characterize and follow the extent of hemodynamic derangement, response to therapy, and as an end point in clinical trials of novel therapy. Therapy for PAH is steadily evolving, with considerable uncertainty regarding optimal dosing and comparative efficacy of the available therapeutic agents. Ambulatory hemodynamic monitoring techniques are under development that facilitate availability of hemodynamic parameters ad libitum. Such techniques provide novel insights into cardiovascular pathophysiology during activity and may prove to be useful in allowing early detection of hemodynamic changes between clinic visits. Hemodynamics obtained from implantable monitors have been used during PAH medical therapy in pilot studies and could be used as an end point in clinical trials of PAH therapy. Future efforts should focus on proof of clinical utility of implantable monitoring and refinement of cardiac output estimation by pressure waveform analysis.",
keywords = "hemodynamics, implantable hemodynamic monitors, pulmonary arterial hypertension, right heart failure",
author = "Robert Frantz",
year = "2011",
month = "4",
doi = "10.1586/ers.11.16",
language = "English (US)",
volume = "5",
pages = "173--178",
journal = "Expert Review of Respiratory Medicine",
issn = "1747-6348",
publisher = "Expert Reviews Ltd.",
number = "2",

}

TY - JOUR

T1 - Hemodynamic monitoring in pulmonary arterial hypertension

AU - Frantz, Robert

PY - 2011/4

Y1 - 2011/4

N2 - Pulmonary arterial hypertension (PAH) is a progressive disease that results in elevation of the pulmonary artery pressure and ultimately development of right ventricular failure. Baseline and periodic invasive hemodynamics via right heart catheterization are generally obtained in order to characterize and follow the extent of hemodynamic derangement, response to therapy, and as an end point in clinical trials of novel therapy. Therapy for PAH is steadily evolving, with considerable uncertainty regarding optimal dosing and comparative efficacy of the available therapeutic agents. Ambulatory hemodynamic monitoring techniques are under development that facilitate availability of hemodynamic parameters ad libitum. Such techniques provide novel insights into cardiovascular pathophysiology during activity and may prove to be useful in allowing early detection of hemodynamic changes between clinic visits. Hemodynamics obtained from implantable monitors have been used during PAH medical therapy in pilot studies and could be used as an end point in clinical trials of PAH therapy. Future efforts should focus on proof of clinical utility of implantable monitoring and refinement of cardiac output estimation by pressure waveform analysis.

AB - Pulmonary arterial hypertension (PAH) is a progressive disease that results in elevation of the pulmonary artery pressure and ultimately development of right ventricular failure. Baseline and periodic invasive hemodynamics via right heart catheterization are generally obtained in order to characterize and follow the extent of hemodynamic derangement, response to therapy, and as an end point in clinical trials of novel therapy. Therapy for PAH is steadily evolving, with considerable uncertainty regarding optimal dosing and comparative efficacy of the available therapeutic agents. Ambulatory hemodynamic monitoring techniques are under development that facilitate availability of hemodynamic parameters ad libitum. Such techniques provide novel insights into cardiovascular pathophysiology during activity and may prove to be useful in allowing early detection of hemodynamic changes between clinic visits. Hemodynamics obtained from implantable monitors have been used during PAH medical therapy in pilot studies and could be used as an end point in clinical trials of PAH therapy. Future efforts should focus on proof of clinical utility of implantable monitoring and refinement of cardiac output estimation by pressure waveform analysis.

KW - hemodynamics

KW - implantable hemodynamic monitors

KW - pulmonary arterial hypertension

KW - right heart failure

UR - http://www.scopus.com/inward/record.url?scp=79955419207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955419207&partnerID=8YFLogxK

U2 - 10.1586/ers.11.16

DO - 10.1586/ers.11.16

M3 - Article

C2 - 21510728

AN - SCOPUS:79955419207

VL - 5

SP - 173

EP - 178

JO - Expert Review of Respiratory Medicine

JF - Expert Review of Respiratory Medicine

SN - 1747-6348

IS - 2

ER -